Drugs / Pfizer/BNT
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05605470 Comparator | Jan 2023 → Jul 2024 | COVID-19 | Technovalia, Pty Ltd | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pfizer/BNT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05605470 ↗ |
| Known as | Comirnaty | “Participants will be randomized to receive Comirnaty® (Pfizer/BNT) vaccine (30 mcg) given by IM (n=25)” NCT05605470 ↗ |
| Modality | Vaccine | “Pfizer/BNT vaccine (30 mcg)” NCT05605470 ↗ |
| Route | Intramuscular | “Single dose of Pfizer/BNT vaccine 0.3 ml will be given by IM at Day 1” NCT05605470 ↗ |